Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Menicon Co ( (JP:7780) ).
Menicon’s board has approved agenda items for its 69th annual general meeting of shareholders on June 26, 2026, including the election of eight directors. Six incumbents, among them President and CEO Koji Kawaura and three outside directors, are nominated for reappointment, while attorney Yumi Takeuchi and former Benesse executive officer Katsuhiko Masumoto are proposed as new directors, signaling an emphasis on legal expertise and broader management experience.
Shareholders will also be asked to approve stock option plans for directors and employees of Menicon’s subsidiaries, covering both domestic residents and nonresidents. These share acquisition rights, issued gratis with a nominal exercise price, are designed to align subsidiary management and staff incentives with group-wide performance and corporate value enhancement, potentially strengthening governance and long-term growth across the Menicon group.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen1900.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
More about Menicon Co
Menicon Co., Ltd., listed on the TSE Prime and NSE Premier markets, operates in the ophthalmic and contact lens industry. The company focuses on eye care–related products and services and manages a group structure with multiple subsidiaries in Japan and overseas, reflecting a strategy aimed at sustained business performance and corporate value growth.
Average Trading Volume: 263,853
Technical Sentiment Signal: Hold
Current Market Cap: Yen122.4B
For an in-depth examination of 7780 stock, go to TipRanks’ Overview page.